A Phase II Trial of MLN8237 in Patients With Metastatic Castrate Resistant and Neuroendocrine Prostate Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Himisha Beltran, MD
Weill Medical College of Cornell University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Chicago
Chicago, Illinois, United States
- Karmanos Cancer Institute
Detroit, Michigan, United States
- Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Weill Cornell Medical College
New York, New York, United States
- Duke University Health System
Durham, North Carolina, United States
- University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
- University of Washington Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2013
- Primary completion
- 31 Jul 2016
- Completion
- 31 Aug 2017
- Last update posted
- 23 Jan 2018
- Registered enrollment
- 60
- Registry id
- NCT01799278
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.